HALO
Halozyme Therapeutics Inc.
$78.28
+$0.47(+0.60%)
70
Overall
60
Value
81
Tech
--
Quality
Market Cap
$9.10B
Volume
1.62M
52W Range
$42.01 - $77.95
Target Price
$70.56
Key Metrics Overview
| Market Cap | $9.10B | P/E Ratio | 13.38 |
| 52W High | $77.95 | 52W Low | $42.01 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | 7.0% | 52W Position | 100.9% |
| Overall Score | 70 | Value Score | 60 |
| Quality Score | -- | Technical Score | 81 |
Growth Analysis
| EPS Current Est | $5.85 | EPS Next Est | $7.24 |
| EPS Growth Est | +23.8% | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | HALO | $78.28 | +0.6% | 1.62M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Halozyme Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW